Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065765
Filing Date
2025-05-07
Accepted
2025-05-07 16:30:39
Documents
86
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20250331.htm   iXBRL 10-Q 2797907
2 EX-31.1 inva-ex31_1.htm EX-31.1 14340
3 EX-31.2 inva-ex31_2.htm EX-31.2 14341
4 EX-32 inva-ex32.htm EX-32 22776
  Complete submission text file 0000950170-25-065765.txt   13441109

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inva-20250331.xsd EX-101.SCH 1857768
89 EXTRACTED XBRL INSTANCE DOCUMENT inva-20250331_htm.xml XML 2864250
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 25921947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)